Romedahl MedScience ApS: Financial statements 2022
CVR: 38540580
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Romedahl MedScience ApS (CVR 38540580) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -4,945 compared with DKK -7,940 the year before. Equity in the 2022 report amounted to DKK 21,681. The solvency ratio was 65.3%. The company had 1 employee in the financial year.
- Profit/Loss
- DKK -4,945
- Equity
- DKK 21,681
- Total Assets
- DKK 33,182
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | - | -5 t. | 22 t. | 1 |
| 2021 | - | - | -8 t. | 27 t. | 1 |
| 2020 | - | - | -9 t. | -5 t. | 1 |
| 2019 | - | 0 | 0 | 4 t. | 0 |
| 2018 | 0 | 0 | 0 | 4 t. | - |
Official annual report
Keep an eye on Romedahl MedScience ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Romedahl MedScience ApS has published its annual report for 2021. The net result was DKK -7,940.
About Romedahl MedScience ApS
Romedahl MedScience ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2017. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Romedahl MedScience IVS. The management consists of Hanne Risager Romedahl. The company is owned by Hanne Risager Romedahl. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK -8,552 compared with DKK -6,398 the year before. Equity in the 2025 report amounted to DKK 642.